Results for tag: "Nasopharyngeal Cancer Drug"

Nasopharyngeal cancer is a type of cancer that affects the nasopharynx, the upper part of the throat behind the nose. Oncology drugs are used to treat this type of cancer. These drugs are typically administered intravenously or orally, and may include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells. Immunotherapy drugs are used to stimulate the body's immune system to fight cancer cells. The nasopharyngeal cancer drug market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of nasopharyngeal cancer, as well as the development of new drugs and treatments. The market is expected to continue to grow in the coming years, as more drugs are developed and approved for use. Some companies in the nasopharyngeal cancer drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more